Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Oncology

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDG500PMID 14630678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N9741: FOLFOX (oxaliplatin(Oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study.

  2004cited by this paper
• Discrepancy between Consensus Recommendations and Actual Community Use of Adjuvant Chemotherapy in Women with Breast Cancer

  2003cited by this paper
• 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.

  2003cited by this paper
• Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials.

  2002cited by this paper
• Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients

  2002cited by this paper
• First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.

  2002influential reference
• Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.

  2002cited by this paper
• Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.

  2001cited by this paper
• Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

  2001cited by this paper
• Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study.

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000influential reference
• Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

  1999cited by this paper
• Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.

  1999cited by this paper
• Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

  1998cited by this paper
• Patient preferences for oral versus intravenous palliative chemotherapy.

  1997cited by this paper
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

  1995cited by this paper
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators.

  1995cited by this paper
• A study of quality of life in cancer patients receiving palliative chemotherapy.

  1992cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Preventing Hand-Foot Syndrome in Patients With Cancer: A Systematic Review and Network Meta-Analysis.

  2026cites this paper
• Optimizing fluoropyrimidine therapy: Real‐world impact of DPYD genotype‐based dosing on severe toxicity rates

  2025cites this paper
• Review of the fluoropyrimidine antidote uridine triacetate

  2024cites this paper
• Updates on the Management of Colorectal Cancer in Older Adults

  2024cites this paper
• Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer

  2024cites this paper
• The Prevalence of 5-Fluorouracil and Capecitabine Cardiotoxicity: A Systematic Review and Meta-Analysis

  2024cites this paper
• Commonly prescribed medications associated with alopecia.

  2023cites this paper
• Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial

  2023cites this paper
• Intake and biomarkers of folate and folic acid as determinants of chemotherapy-induced toxicities in patients with colorectal cancer: a cohort study.

  2023cites this paper
• The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China

  2023cites this paper
• Lanolin-based dexpanthenol cream, topical hydrocortisone or observation in the prevention of capecitabine-induced hand-foot syndrome: a phase III trial

  2022cites this paper
• Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database

  2022cites this paper
• The Impact of Pelvic Nodal Radiotherapy on Hematologic Toxicity: A Systematic Review with Focus on Leukopenia, Lymphopenia and Future Perspectives in Prostate Cancer Treatment.

  2021cites this paper
• Clinical characteristics and survival of colorectal cancer patients in Korea stratified by age

  2021cites this paper
• Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS/MS.

  2021cites this paper
• Selection of Oral Therapeutics in China for the Treatment of Colorectal Cancer

  2021cites this paper
• Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone.

  2021cites this paper
• A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

  2021cites this paper
• Performance of capecitabine in novel combination therapies in colorectal cancer

  2021cites this paper
• Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade

  2020cites this paper
• A SIMPLE SYNTHESIS, OF SOME NOVEL BI-THIAZOLES AS ANTI-TUMOR AGENTS

  2020cites this paper
• Digestive Organ Aging and Cancer

  2020cites this paper
• Pharmacokinetic Considerations for Organ Dysfunction Clinical Trials in Early Drug Development

  2020cites this paper
• identifying factors associated with underuse of adjuvant chemotherapy for stage iii colon cancer

  2019cites this paper
• ASSESSMENT of HEMATOLOGICAL PARAMETERS BEFORE and AFTER ADJUVANT CHEMOTHERAPY in PATIENTS with COLORECTAL CANCER

  2019cites this paper
• A stereo-selective growth inhibition profile of ginsenoside Rh2 on human colon cancer cells

  2019cites this paper
• Capecitabine safety profile, innovative and generic adjuvant formulation of nonmetastatic colorectal cancer.

  2019cites this paper
• Current Treatment Strategies for Elderly Patients with Metastatic Colon Cancer

  2019cites this paper
• Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study.

  2019cites this paper
• Regorafenib-Induced Hand–Foot Skin Reaction Is More Severe on the Feet Than on the Hands

  2019cites this paper
• Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives.

  2019cites this paper
• Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles

  2018cites this paper
• A cross-sectional survey of methods for controling hand-foot syndrome in patients receiving capecitabine treatment.

  2018cites this paper
• Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer.

  2018cites this paper
• A rapid and simple HPTLC assay for therapeutic drug monitoring of capecitabine in colorectal cancer patients.

  2018cites this paper
• Colorektales Karzinom – Besondere Aspekte in der Versorgung alter und geriatrischer Patienten

  2018cites this paper
• Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review.

  2017cites this paper
• Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas.

  2017cites this paper
• The short-term impact of colorectal cancer treatment on physical activity, functional status and quality of life: a systematic review

  2017cites this paper
• Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine

  2017cites this paper
• Oral versus intravenous fluoropyrimidines for colorectal cancer.

  2017cites this paper
• Is it time to address survivorship in advanced breast cancer? A review article.

  2017cites this paper
• Recurrence‐free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy

  2017cites this paper
• Adjuvant Chemotherapy Among Elderly Colon Cancer Patients : from gut feeling towards evidence-based use in clinical practice : Adjuvante chemotherapie bij oudere patiënten met dikkedarmkanker : van onderbuikgevoel naar wetenschappelijk bewijs voor gebruik in de klinische praktijk

  2016cites this paper
• Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients.

  2016cites this paper
• Prognostic significance of perineural invasion in stage IIA colon cancer

  2016cites this paper
• [Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].

  2016cites this paper
• Psoriasis aggravation due to capecitabine in a colon cancer patient : a case report and literature review

  2016cites this paper
• Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution

  2016cites this paper
• A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine

  2016cites this paper
• Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline.

  2016cites this paper
• Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach

  2016cites this paper
• Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial

  2016cites this paper
• Long-Term Bone Marrow Suppression During Postoperative Chemotherapy in Rectal Cancer Patients After Preoperative Chemoradiation Therapy.

  2016cites this paper
• Management of Colorectal Cancer in Older Adults.

  2016cites this paper
• Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patients.

  2016cites this paper
• The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients

  2016cites this paper
• Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer

  2016cites this paper
• Risk Factors Exacerbating Hand-Foot Skin Reaction Induced by Capecitabine plus Oxaliplatin with or without Bevacizumab Therapy

  2015cites this paper
• Phase II multi-center clinical study on using S-1 to treat advanced breast cancer after resistance to anthracycline and taxane drugs in Chinese patients.

  2015cites this paper
• Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

  2015cites this paper
• Treatment of colorectal cancer in the elderly.

  2015cites this paper
• Observational study of adjuvant therapy with capecitabine in colon cancer

  2015cites this paper
• Неоадъювантная химиолучевая терапия местно-распространенного рака прямой кишки

  2015cites this paper
• Types of Cancers Prevailing in Pakistan and their Management Evaluation.

  2015cites this paper
• The short‐term impact of curative colorectal cancer treatment on physical activity, functional status and quality of life: a systematic review protocol

  2015cites this paper
• Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG).

  2015cites this paper
• Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.

  2015cites this paper
• Capecitabine pattern of usage, rate of febrile neutropaenia and treatment related death in asian cancer patients in clinical practice.

  2015cites this paper
• The relevance of OATP4A1 in human colon cancer and diverticulitis specimens

  2014cites this paper
• Acute coronary artery thrombosis and vasospasm following capecitabine in conjunction with oxaliplatin treatment for cancer

  2014cites this paper
• Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy.

  2014cites this paper
• Cost-Effectiveness of Aspirin Adjuvant Therapy in Early Stage Colorectal Cancer in Older Patients

  2014cites this paper
• Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer

  2014cites this paper
• Refining the chemotherapy approach for older patients with colon cancer.

  2014cites this paper
• Pharmakokinetik und metabolische Aktivierung von Capecitabin in der Kombinationstherapie mit Oxaliplatin und dem monoklonalen Antikörper Cetuximab

  2014cites this paper
• Adjuvant chemotherapy outcomes in patients over 65 years with early stage colorectal carcinoma.

  2014cites this paper
• Clinical pharmacokinetics of capecitabine and its metabolites in combination with the monoclonal antibody bevacizumab.

  2014cites this paper
• Optimal management of colorectal liver metastases in older patients: a decision analysis.

  2014cites this paper
• Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings

  2014cites this paper
• Human liver carboxylesterase 1 structure, polymorphism and its role in drug and prodrug activation and metabolism

  2014cites this paper
• Adjuvant Chemotherapy for Senior Patients After Resection of Colon Cancer

  2013cites this paper
• Budgetary impact of oral chemotherapy incorporation in Brazil : a real world data analysis from the private payer perspective

  2013cites this paper
• Artigo Original Original Article

  2013cites this paper
• Colorectal cancer in elderly patients: from best supportive care to cure.

  2013cites this paper
• Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer.

  2013cites this paper
• Equity in an equal access system? -- Quality & timeliness of cancer care in the Veterans Affairs healthcare system

  2013cites this paper
• Pharmakokinetik von Capecitabin in der Dreifachkombinations-Chemotherapie mit Oxaliplatin und Cetuximab

  2013influential citation
• Comparative Effectiveness of Adjuvant Chemotherapy in Elderly Colon Cancer Patients

  2013cites this paper
• Neo-adjuvant Capecitabine Chemotherapy in Women with Newly Diagnosed Locally Advanced Breast Cancer in a Resource-poor Setting (Nigeria): Efficacy and Safety in a Phase II Feasibility Study

  2013cites this paper
• Pharmacology of aging and cancer: how useful are pharmacokinetic tests?.

  2013cites this paper
• Elimination of esophageal multiple precancerous lesions by chemotherapy: potential chemoprevention of metachronous multiple cancer development after curative treatment

  2012cites this paper
• Effects of preoperative radiochemotherapy with capecitabine for resectable locally advanced rectal cancer in elderly patients.

  2012cites this paper
• Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.

  2012cites this paper
• Effects of Preoperative Radiochemotherapy with Capecitabine for Resectable Locally Advanced Rectal Cancer in Elderly Patients

  2012cites this paper
• Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer.

  2012cites this paper
• STABILITY STUDY OF CAPECITABINE ACTIVE PHARMACEUTICAL INGREDIENT IN BULK DRUG AND PHARMACEUTICAL FORMULATION

  2012cites this paper
• A multigene prognostic assay for selection of adjuvant chemotherapy in patients with T3, stage II colon cancer: impact on quality-adjusted life expectancy and costs.

  2012cites this paper
• Clinical update: colon, rectal, and anal cancers.

  2012cites this paper
• A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer

  2012cites this paper